Promsote, Wanwisa <br/><br/>
Oral Monomethyl Fumarate Therapy Ameliorates Retinopathy in a Humanized Mouse Model of Sickle Cell Disease.  [electronic resource] 

 -  Antioxidants & redox signaling  12 2016 
 - 921-935 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1557-7716 
<br/><br/><label>Standard No.: </label>10.1089/ars.2016.6638  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Anemia, Sickle Cell--blood<br/>Animals<br/>Blood-Retinal Barrier--metabolism<br/>Carrier Proteins--genetics<br/>DNA-Binding Proteins<br/>Disease Models, Animal<br/>Electroretinography<br/>Fumarates--administration & dosage<br/>Gene Expression<br/>Gene Expression Regulation<br/>Humans<br/>Intercellular Adhesion Molecule-1--genetics<br/>Mice<br/>NF-E2-Related Factor 2--metabolism<br/>Neovascularization, Pathologic<br/>Nuclear Proteins--genetics<br/>Oxidative Stress--drug effects<br/>Repressor Proteins<br/>Retina--drug effects<br/>Retinal Diseases--drug therapy<br/>Retinal Neurons--drug effects<br/>Retinal Pigment Epithelium--drug effects<br/>Vascular Endothelial Growth Factor A--genetics<br/>gamma-Globulins--genetics